Data search


search
Exact
Search

Results for MligTC455_20332

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_20332 34 0.71 Mlig455_038515

Neo: -

Age: -

Mlig455_038515 {REF} {Length: 2092} {RNA1509_52468} {RNA1310_41235} {RNA815_11414.1}

Cumulative graph for MligTC455_20332

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 4.339 0.972 0.99976 1.00000
RegionR2 -1.134 0.972 0.94612 1.00000
RegionR3 -3.318 0.972 0.99967 1.00000
RegionR4 3.069 0.972 0.03618 0.15496
RegionR5 -2.439 0.972 0.99966 1.00000
RegionR6 -2.496 0.972 0.94584 1.00000
RegionR7 3.973 0.972 0.01077 0.18036
RegionR8 -1.994 0.972 0.99962 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -6.955 0.972 0.99991 1.00000
RegenerationR2 -0.431 0.972 0.41616 0.82462
RegenerationR3 0.068 0.972 0.73261 0.95866
RegenerationR4 -4.093 0.972 0.01661 0.20215
RegenerationR5 -1.616 0.972 0.82003 0.99436
RegenerationR6 -1.471 0.972 0.38766 0.72776
RegenerationBL -5.202 0.972 0.99970 1.00000
RegenerationTP -5.758 0.972 0.99971 1.00000


Genes with expression patterns similar to MligTC455_20332

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_20332 34 0.71 Mlig455_038515

Neo: -

Age: -

4 1.000 - 1.000 1.000 1.000 - Mlig455_038515 {REF} {Length: 2092} {RNA1509_52468} {RNA1310_41235} {RNA815_11414.1}
2. MligTC455_48909 93 1.94 Mlig455_048405, Mlig455_049069

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-0.490

Region-enriched R2: 4.721/0.03142
Region-enriched R7: 4.417/0.01493

ASIC1 2.747 - - 0.906 0.958 0.883 -

Mlig455_048405 {REF} {Length: 2732} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=163.8]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=51.6, Expect=4e-06]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=55.8, Expect=1e-07]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=55.1, Expect=2e-07]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=112, Expect=8e-26]} {RNA1310_26678} {RNA815_24347}

Mlig455_049069 {REF} {Length: 2732} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=163.8]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=51.2, Expect=5e-06]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=55.8, Expect=1e-07]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=55.1, Expect=2e-07]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=112, Expect=8e-26]} {RNA1310_26678} {RNA815_24347}
3. MligTC455_52727 82 1.72 Mlig455_043336

Neo: -

Age: Down-Up-Down

2.488 - - 0.701 0.836 0.951 - Mlig455_043336 {REF} {Length: 1410} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=60.5]; Capsular polysaccharide synthesis protein [PF05704.14, score=20.9]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=131, Expect=4e-35]} {RNA1509_41314} {RNA1310_26265} {RNA815_9794.1}
4. MligTC455_23547 43 0.89 Mlig455_025198

Neo: -

Age: -

2.482 - - 0.764 0.750 0.968 - Mlig455_025198 {REF} {Length: 1912} {RNA1310_62305} {RNA815_43403}
5. MligTC455_24951 220 4.58 Mlig455_052169

Neo: -

Age: -

Region-specific R2: 4.554

Region-enriched R2: 4.264/0.00008

Regeneration-downregulated R2: -1.743

Regeneration-depleted R2: -1.743

CCDC169 2.431 - - 0.727 0.743 0.961 - Mlig455_052169 {REF} {Length: 1369} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545}
6. MligTC455_38813 50 1.04 Mlig455_008881

Neo: -

Age: Up-Down-Down

Region-enriched R2: 5.104/0.01060

THSD7A 1.918 - - - 0.964 0.954 - Mlig455_008881 {REF} {Length: 6770} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=138.6]; Thrombospondin type 1 domain [PF19030.2, score=34.2]; Thrombospondin type 1 domain [PF00090.21, score=26.3]} {Human: ENSG00000005108, THSD7A, thrombospondin type 1 domain containing 7A, [Score=298, Expect=5e-81]} {Mouse: ENSMUSG00000032625, Thsd7a, thrombospondin, type I, domain containing 7A, [Score=303, Expect=8e-83]} {Celegans: WBGene00001650, gon-1, A disintegrin and metalloproteinase with thrombospondin motifs gon-1, [Score=54.7, Expect=8e-07]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=50.4, Expect=1e-05]} {RNA1310_90350}
7. MligTC455_33257 441 9.18 Mlig455_032762

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.898

Region-enriched R7: 7.302/0.00324

ADAMTS1 1.891 0.994 - - - 0.897 - Mlig455_032762 {REF} {Length: 2204} {Pfam: Metallo-peptidase family M12 [PF13688.8, score=49.6]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=41.2]; Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=41.1]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=35.5]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=29.0]; ADAM cysteine-rich domain [PF17771.3, score=25.4]} {Human: ENSG00000154734, ADAMTS1, ADAM metallopeptidase with thrombospondin type 1 motif 1, [Score=74.7, Expect=3e-13]; ENSG00000145808, ADAMTS19, ADAM metallopeptidase with thrombospondin type 1 motif 19, [Score=74.3, Expect=5e-13]} {Mouse: ENSMUSG00000006403, Adamts4, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4, [Score=70.5, Expect=5e-12]; ENSMUSG00000022893, Adamts1, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1, [Score=68.9, Expect=2e-11]; ENSMUSG00000031994, Adamts8, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 8, [Score=68.6, Expect=2e-11]; ENSMUSG00000053441, Adamts19, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 19, [Score=68.6, Expect=2e-11]} {Dmel: FBgn0034903, sona, sol narae, [Score=73.2, Expect=5e-13]} {Celegans: WBGene00003248, mig-17, ADAM family mig-17, [Score=57.0, Expect=3e-08]} {RNA1509_380} {RNA1310_14719} {RNA815_5216}
8. MligTC455_45683 346 7.21 Mlig455_067172

Neo: -

Age: Down-Up-Down

Region-enriched R7: 4.371/0.00009

1.889 - - 0.936 0.953 - - Mlig455_067172 {REF} {Length: 932} {Pfam: Late nodulin protein [PF07127.13, score=20.1]} {RNA1310_45419} {RNA815_22274}
9. MligTC455_40649 24 0.49 Mlig455_066232

Neo: -

Age: -

1.879 - - - 0.968 0.911 - Mlig455_066232 {REF} {Length: 2453} {RNA1310_42980.1} {RNA815_47590}
10. MligTC455_47741 102 2.13 Mlig455_004211

Neo: -

Age: Down-Up-Up

1.873 - - - 0.912 0.961 - Mlig455_004211 {REF} {Length: 1794} {RNA1310_23101} {RNA815_45601}
11. MligTC455_51780 138 2.88 Mlig455_046894

Neo: -

Age: Down-Up-Down

Region-enriched R2: 6.174/0.00338

PNPO 1.848 - - - 0.875 0.973 - Mlig455_046894 {REF} {Length: 2339} {Pfam: Pyridoxamine 5'-phosphate oxidase [PF01243.22, score=78.4]; Pyridoxine 5'-phosphate oxidase C-terminal dimerisation region [PF10590.11, score=69.2]; Pyridoxamine 5'-phosphate oxidase [PF12766.9, score=22.3]} {Human: ENSG00000108439, PNPO, pyridoxamine 5'-phosphate oxidase, [Score=182, Expect=7e-57]} {Mouse: ENSMUSG00000018659, Pnpo, pyridoxine 5'-phosphate oxidase, [RH, Score=184, Expect=1e-57]} {Dmel: FBgn0051472, sgll, sugarlethal, [Score=168, Expect=6e-52]} {Celegans: WBGene00018996, F57B9.1, Putative pyridoxamine 5'-phosphate oxidase, [RH, Score=200, Expect=1e-64]} {Smed: dd_Smed_v6_5086_0_1, dd_Smed_v6_5086_0_1, [RH, Score=177, Expect=2e-55]} {RNA1509_54079} {RNA1310_31564.1, RNA1509_54079} {RNA1509_54079, RNA815_34098}
12. MligTC455_27673 123 2.56 Mlig455_041241, Mlig455_053095

Neo: -

Age: Up-Down-Up

GLRA1, GLRA3 1.841 - - - 0.864 0.977 -

Mlig455_041241 {REF} {Length: 4857} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=165.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.7]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=253, Expect=3e-78]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=249, Expect=9e-77]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=246, Expect=1e-75]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=246, Expect=7e-76]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=244, Expect=2e-74]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=243, Expect=1e-74]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=240, Expect=2e-73]} {Dmel: FBgn0024963, GluClalpha, [Score=256, Expect=1e-79]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [RH, Score=247, Expect=6e-76]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=440, Expect=1e-151]} {RNA1509_35986} {RNA1310_28655} {RNA815_20247}

Mlig455_053095 {REF} {Length: 4892} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=163.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=83.4]} {Human: ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=254, Expect=9e-79]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=251, Expect=1e-77]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=243, Expect=9e-75]} {Mouse: ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=9e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=244, Expect=5e-75]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=242, Expect=4e-74]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=236, Expect=2e-72]} {Dmel: FBgn0024963, GluClalpha, [Score=257, Expect=4e-80]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=252, Expect=3e-78]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=449, Expect=1e-155]} {RNA1509_54479} {RNA1310_56579} {RNA815_20247}
13. MligTC455_16866 18 0.37 Mlig455_065296

Neo: -

Age: -

1.84 - - - 0.856 0.984 - Mlig455_065296 {REF} {Length: 1827} {RNA1310_92472}
14. MligTC455_16867 18 0.37 Mlig455_065319

Neo: -

Age: -

1.84 - - - 0.856 0.984 - Mlig455_065319 {REF} {Length: 1743} {RNA1310_92472}
15. MligTC455_47704 106 2.21 Mlig455_032247

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.432

WSCD2 1.829 - - - 0.845 0.984 - Mlig455_032247 {REF} {Length: 2305} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.7, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.6, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-10]} {RNA1509_59284} {RNA1310_13567} {RNA815_27780}
16. MligTC455_19578 23 0.47 Mlig455_018093, Mlig455_059526

Neo: -

Age: -

1.828 - - - 0.862 0.966 -

Mlig455_018093 {REF} {Length: 2450} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=99.2]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=72.4, Expect=4e-13]} {RNA1310_65251}

Mlig455_059526 {REF} {Length: 2621} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=74.7, Expect=8e-14]} {RNA1310_65251}
17. MligTC455_40477 87 1.8 Mlig455_066098, Mlig455_068673

Neo: -

Age: -

Regeneration-downregulated R4: -4.243

Regeneration-depleted R4: -4.243

SSUH2 1.819 0.851 - - 0.968 - -

Mlig455_066098 {REF} {Length: 1581} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=108, Expect=1e-26]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=104, Expect=3e-25]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=69.3, Expect=4e-13]} {RNA1310_23200} {RNA815_29266}

Mlig455_068673 {REF} {Length: 1558} {Pfam: DnaJ central domain [PF00684.21, score=24.8]} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [RH, Score=216, Expect=8e-66]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=165, Expect=6e-47]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [RH, Score=140, Expect=2e-37]} {RNA1310_23200} {RNA815_29266}
18. MligTC455_49620 290 6.04 Mlig455_001138, Mlig455_001300

Neo: -

Age: -

Region-enriched R2: 5.198/0.00000

ELAVL3, ELAVL4 1.815 - - - 0.855 0.960 -

Mlig455_001138 {REF} {Length: 3131} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=206.7]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=37.5]; Occluded RNA-recognition motif [PF16842.7, score=27.0]} {Human: ENSG00000162374, ELAVL4, ELAV like RNA binding protein 4, [Score=268, Expect=6e-85]; ENSG00000196361, ELAVL3, ELAV like RNA binding protein 3, [Score=268, Expect=3e-85]; ENSG00000107105, ELAVL2, ELAV like RNA binding protein 2, [Score=268, Expect=2e-84]} {Mouse: ENSMUSG00000003410, Elavl3, ELAV like RNA binding protein 3, [RH, Score=270, Expect=2e-87]} {Dmel: FBgn0010263, Rbp9, RNA-binding protein 9, [Score=273, Expect=2e-86]} {Celegans: WBGene00001368, exc-7, [RH, Score=327, Expect=6e-107]} {Smed: dd_Smed_v6_13151_0_1, dd_Smed_v6_13151_0_1, [RH, Score=269, Expect=8e-84]} {RNA1509_28072} {RNA1310_22289} {RNA815_15133}

Mlig455_001300 {REF} {Length: 3150} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=203.6]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=36.4]; Occluded RNA-recognition motif [PF16842.7, score=27.0]} {Human: ENSG00000196361, ELAVL3, ELAV like RNA binding protein 3, [Score=274, Expect=4e-87]; ENSG00000162374, ELAVL4, ELAV like RNA binding protein 4, [Score=271, Expect=6e-86]; ENSG00000107105, ELAVL2, ELAV like RNA binding protein 2, [Score=268, Expect=3e-85]; ENSG00000066044, ELAVL1, ELAV like RNA binding protein 1, [Score=262, Expect=3e-83]} {Mouse: ENSMUSG00000003410, Elavl3, ELAV like RNA binding protein 3, [RH, Score=271, Expect=7e-88]} {Dmel: FBgn0010263, Rbp9, RNA-binding protein 9, [Score=270, Expect=4e-85]} {Celegans: WBGene00001368, exc-7, [RH, Score=326, Expect=1e-106]} {Smed: dd_Smed_v6_11311_0_2, dd_Smed_v6_11311_0_2, [RH, Score=300, Expect=2e-97]} {RNA1509_28072} {RNA1310_22289} {RNA815_15133}
19. MligTC455_45414 4030 83.95 Mlig455_045096

Neo: -

Age: Down-Down-Up

Region-specific R2: 2.245

Region-enriched R2: 1.386/0.00025

Regeneration-depleted TP: -1.938
Regeneration-depleted BL: -1.852

1.803 - - - 0.839 0.964 - Mlig455_045096 {REF} {Length: 1427} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1310_24092, RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192, RNA815_369.1}
20. MligTC455_42841 550 11.45 Mlig455_019999

Neo: -

Age: logFC(26M/2M)=-0.374

Region-specific R2: 6.903

Region-enriched R2: 6.896/0.00000

DDC 1.796 - - - 0.824 0.972 - Mlig455_019999 {REF} {Length: 3000} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=395.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [Score=444, Expect=3e-151]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [Score=436, Expect=5e-148]} {Dmel: FBgn0050446, Tdc2, Tyrosine decarboxylase 2, [Score=457, Expect=2e-154]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [Score=445, Expect=1e-149]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [Score=449, Expect=3e-153]} {RNA1509_57403} {RNA1310_9852} {RNA815_3388.1}
21. MligTC455_49862 26 0.54 Mlig455_019435

Neo: -

Age: -

SHOX2 1.792 - - - 0.829 0.963 - Mlig455_019435 {REF} {Length: 904} {Pfam: Homeodomain [PF00046.31, score=84.8]; Homeobox KN domain [PF05920.13, score=23.6]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=89.0, Expect=4e-22]; ENSG00000185960, SHOX, short stature homeobox, [Score=87.0, Expect=5e-21]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=89.0, Expect=3e-22]} {Dmel: FBgn0085396, CG34367, [Score=89.7, Expect=9e-22]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=83.6, Expect=5e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=86.3, Expect=2e-20]} {RNA1310_51707} {RNA815_41055}
22. MligTC455_44999 2214 46.12 Mlig455_067394, Mlig455_069538

Neo: -

Age: Down-Up-Up

Region-enriched R2: 2.840/0.00027

1.79 - - - 0.813 0.977 -

Mlig455_067394 {REF} {Length: 401} {RNA1509_52966} {RNA1310_68651, RNA1509_52966} {RNA1509_52966, RNA815_33112.1}

Mlig455_069538 {REF} {Length: 1759} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=45.8, Expect=1e-06]} {RNA1509_13671} {RNA1310_56061} {RNA815_33112.1}
23. MligTC455_53413 249 5.2 Mlig455_035022

Neo: -

Age: -

Region-specific R2: 4.451

Region-enriched R2: 3.023/0.00460

RP1 1.785 - - - 0.825 0.960 - Mlig455_035022 {REF} {Length: 5065} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_57003} {RNA1310_2710} {RNA815_13802.1}
24. MligTC455_22323 68 1.42 Mlig455_000713, Mlig455_000766

Neo: -

Age: -

HCN4 1.783 - - - 0.809 0.974 -

Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1}

Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1}
25. MligTC455_31031 361 7.53 Mlig455_009779

Neo: -

Age: -

Region-enriched R2: 2.821/0.00350

LRRN3 1.779 - - - 0.798 0.981 - Mlig455_009779 {REF} {Length: 3647} {Pfam: Immunoglobulin domain [PF13927.8, score=35.5]; Immunoglobulin I-set domain [PF07679.18, score=34.5]; Immunoglobulin domain [PF00047.27, score=29.1]; Apolipoprotein A1/A4/E domain [PF01442.20, score=19.2]} {Human: ENSG00000173114, LRRN3, leucine rich repeat neuronal 3, [Score=56.2, Expect=2e-07]} {Dmel: FBgn0032479, CG16974, [RH, Score=116, Expect=3e-26]} {RNA1509_10344} {RNA1310_3046.1} {RNA815_12103}
26. MligTC455_24952 637 13.28 Mlig455_054178, Mlig455_060727

Neo: -

Age: Down-Up-Down

Region-specific R2: 4.165

Region-enriched R2: 3.160/0.00003

Regeneration-downregulated BL: -4.774

Regeneration-depleted BL: -4.774

CCDC169 1.778 - - 0.811 - 0.967 -

Mlig455_054178 {REF} {Length: 1390} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545}

Mlig455_060727 {REF} {Length: 1391} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029, RNA1509_8270} {RNA1509_8270, RNA815_11545}
27. MligTC455_40559 119 2.48 Mlig455_063539

Neo: -

Age: -

FO681492.1 1.774 - - - 0.803 0.971 - Mlig455_063539 {REF} {Length: 2231} {Pfam: C2 domain [PF00168.32, score=40.3]} {Human: ENSG00000277758, FO681492.1, synaptotagmin-15, [Score=74.3, Expect=1e-13]; ENSG00000204176, SYT15, synaptotagmin 15, [Score=73.9, Expect=1e-13]} {Mouse: ENSMUSG00000041479, Syt15, synaptotagmin XV, [Score=65.5, Expect=6e-11]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=52.4, Expect=4e-07]} {RNA1310_23463.1} {RNA815_43860}
28. MligTC455_45135 20518 427.46 Mlig455_055032, Mlig455_055049

Neo: -

Age: -

Region-enriched R2: 1.186/0.02756
Region-enriched R7: 1.141/0.01846

Regeneration-downregulated BL: -2.004

Regeneration-depleted BL: -2.004

PAM 1.773 - - - 0.807 0.966 -

Mlig455_055032 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.5]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.9]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=205, Expect=4e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=4e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=232, Expect=1e-72]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_979} {RNA1310_15063.1} {RNA815_4981}

Mlig455_055049 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.4]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.8]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=205, Expect=3e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=5e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=233, Expect=5e-73]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_32895, RNA1509_979} {RNA1310_15063.1, RNA1509_32895, RNA1509_979} {RNA1509_32895, RNA1509_979, RNA815_4981}
29. MligTC455_44904 1501 31.27 Mlig455_021814

Neo: -

Age: Down-Up-Up

Region-specific R2: 3.865

Region-enriched R2: 3.792/0.00000

1.773 - - - 0.813 0.960 - Mlig455_021814 {REF} {Length: 959} {RNA1509_15805} {RNA1310_67099.1, RNA1509_15805} {RNA1509_15805, RNA815_17533}
30. MligTC455_23100 527 10.99 Mlig455_019660

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.306

Region-enriched R2: 3.360/0.00019

1.772 - - - 0.801 0.971 - Mlig455_019660 {REF} {Length: 2113} {RNA1509_29678} {RNA1310_49452, RNA1509_29678} {RNA1509_29678, RNA815_4585}
31. MligTC455_44713 661 13.77 Mlig455_048154

Neo: -

Age: logFC(26M/2M)=0.569

Region-specific R2: 3.883

Region-enriched R2: 3.422/0.00000

1.771 - - - 0.798 0.973 - Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074}
32. MligTC455_45134 9943 207.14 Mlig455_022505

Neo: -

Age: -

Region-enriched R2: 1.329/0.00560
Region-enriched R7: 1.024/0.03586

Regeneration-downregulated BL: -1.932

Regeneration-depleted BL: -1.932

PAM 1.768 - - - 0.802 0.966 - Mlig455_022505 {REF} {Length: 1757} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=107.0]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=69.2]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=190, Expect=4e-54]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=186, Expect=7e-53]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [Score=219, Expect=5e-69]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [Score=224, Expect=8e-72]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [Score=255, Expect=4e-83]} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1310_15063.1, RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118, RNA815_4981}
33. MligTC455_36416 57 1.19 Mlig455_064826

Neo: -

Age: -

1.766 - - - 0.971 0.795 - Mlig455_064826 {REF} {Length: 1774} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.5]} {RNA1310_14662} {RNA815_33830}
34. MligTC455_44712 665 13.86 Mlig455_017186

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.471

Region-specific R2: 4.141

Region-enriched R2: 3.536/0.00000

1.76 - - - 0.788 0.972 - Mlig455_017186 {REF} {Length: 1018} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074}
35. MligTC455_25915 4499 93.72 Mlig455_005297

Neo: -

Age: -

Region-enriched R2: 1.495/0.00336

Regeneration-downregulated BL: -1.833

Regeneration-depleted BL: -1.833

CPE 1.756 - - - 0.790 0.966 - Mlig455_005297 {REF} {Length: 3239} {Pfam: Zinc carboxypeptidase [PF00246.26, score=188.0]; Carboxypeptidase regulatory-like domain [PF13620.8, score=23.3]} {Human: ENSG00000109472, CPE, carboxypeptidase E, [Score=322, Expect=8e-105]} {Mouse: ENSMUSG00000037852, Cpe, carboxypeptidase E, [Score=318, Expect=1e-103]} {Dmel: FBgn0004648, svr, silver, [Score=225, Expect=2e-68]} {Celegans: WBGene00001189, egl-21, Carboxypeptidase E, [RH, Score=333, Expect=5e-110]} {Smed: dd_Smed_v6_3059_0_1, dd_Smed_v6_3059_0_1, [RH, Score=384, Expect=7e-130]} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1310_4621.1, RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908, RNA815_1336.1}
36. MligTC455_48603 1006 20.95 Mlig455_058556

Neo: -

Age: -

Region-enriched R2: 1.380/0.01205

Regeneration-downregulated BL: -2.368

Regeneration-depleted BL: -2.368

CALM2 1.755 - - - 0.785 0.970 - Mlig455_058556 {REF} {Length: 2727} {TRANSSPLICED} {Pfam: EF-hand domain pair [PF13499.8, score=101.0]; EF hand [PF00036.34, score=97.2]; EF-hand domain pair [PF13833.8, score=81.7]; EF-hand domain [PF13405.8, score=78.5]; EF hand [PF13202.8, score=71.6]; EF-hand domain [PF14658.8, score=41.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.3]; Dockerin type I domain [PF00404.20, score=25.5]; SurA N-terminal domain [PF13624.8, score=19.1]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=132, Expect=1e-37]; ENSG00000160014, CALM3, calmodulin 3, [Score=130, Expect=5e-37]; ENSG00000198668, CALM1, calmodulin 1, [Score=130, Expect=3e-37]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=135, Expect=8e-39]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=130, Expect=3e-37]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=130, Expect=3e-37]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=127, Expect=3e-36]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=127, Expect=2e-36]} {Smed: dd_Smed_v6_12048_0_2, dd_Smed_v6_12048_0_2, [RH, Score=163, Expect=8e-49]} {RNA1509_36324, RNA1509_52694, RNA1509_5720} {RNA1310_6210.2, RNA1509_36324, RNA1509_52694, RNA1509_5720} {RNA1509_36324, RNA1509_52694, RNA1509_5720, RNA815_4293.1}
37. MligTC455_38780 235 4.89 Mlig455_000360, Mlig455_056487

Neo: -

Age: -

Region-enriched R2: 3.921/0.00457

SGSM1 1.75 - - - 0.796 0.954 -

Mlig455_000360 {REF} {Length: 3015} {Pfam: Rab-GTPase-TBC domain [PF00566.20, score=53.6]; RUN domain [PF02759.21, score=45.8]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [Score=170, Expect=8e-43]} {Mouse: ENSMUSG00000042216, Sgsm1, small G protein signaling modulator 1, [Score=165, Expect=2e-41]} {Dmel: FBgn0052506, CG32506, [Score=150, Expect=1e-36]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=184, Expect=7e-48]} {Smed: dd_Smed_v6_12130_0_1, dd_Smed_v6_12130_0_1, [Score=196, Expect=1e-51]} {RNA1310_67163} {RNA815_24450}

Mlig455_056487 {REF} {Length: 3063} {Pfam: Rab-GTPase-TBC domain [PF00566.20, score=52.8]; RUN domain [PF02759.21, score=45.7]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [Score=171, Expect=6e-43]} {Mouse: ENSMUSG00000042216, Sgsm1, small G protein signaling modulator 1, [Score=166, Expect=2e-41]} {Dmel: FBgn0052506, CG32506, [Score=150, Expect=9e-37]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=183, Expect=2e-47]} {Smed: dd_Smed_v6_12130_0_1, dd_Smed_v6_12130_0_1, [Score=193, Expect=2e-50]} {RNA1310_67163} {RNA815_24450}
38. MligTC455_44861 2493 51.93 Mlig455_012204, Mlig455_069065

Neo: -

Age: -

Region-specific R2: 2.926

Region-enriched R2: 2.403/0.00000

Regeneration-downregulated BL: -1.850

Regeneration-depleted BL: -1.850

QPCT 1.75 - - - 0.796 0.954 -

Mlig455_012204 {REF} {Length: 1746} {Pfam: Peptidase family M28 [PF04389.19, score=139.1]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [RH, Score=186, Expect=7e-56]; ENSG00000011478, QPCTL, glutaminyl-peptide cyclotransferase like, [RH, Score=181, Expect=2e-53]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [RH, Score=184, Expect=6e-55]; ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [RH, Score=184, Expect=2e-55]} {Dmel: FBgn0036999, isoQC, iso Glutaminyl cyclase, [RH, Score=208, Expect=8e-65]} {Celegans: WBGene00010418, H27A22.1, [Score=183, Expect=2e-55]} {Smed: dd_Smed_v6_4861_0_2, dd_Smed_v6_4861_0_2, [Score=162, Expect=3e-47]} {RNA1509_15042} {RNA1310_21925} {RNA815_8635.2}

Mlig455_069065 {REF} {Length: 1718} {Pfam: Peptidase family M28 [PF04389.19, score=83.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=133, Expect=1e-36]; ENSG00000011478, QPCTL, glutaminyl-peptide cyclotransferase like, [Score=128, Expect=1e-34]} {Mouse: ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=138, Expect=1e-38]; ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=135, Expect=2e-37]} {Dmel: FBgn0036999, isoQC, iso Glutaminyl cyclase, [Score=157, Expect=3e-46]} {Celegans: WBGene00010418, H27A22.1, [Score=148, Expect=9e-43]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=119, Expect=8e-32]} {RNA1509_15042} {RNA1310_21925} {RNA815_8635.2}
39. MligTC455_25914 4684 97.58 Mlig455_004975

Neo: -

Age: Up-Down-Up, logFC(26M/2M)=0.418

Region-enriched R2: 1.471/0.00163

Regeneration-downregulated BL: -1.843

Regeneration-depleted BL: -1.843

1.749 - - - 0.783 0.966 - Mlig455_004975 {REF} {Length: 5220} {RNA1509_1158, RNA1509_11723} {RNA1310_4621.1, RNA1509_11723} {RNA1509_11723, RNA815_1336.1}
40. MligTC455_18097 35 0.72 Mlig455_009236

Neo: -

Age: Down-Down-Down

Region-enriched R2: 6.206/0.03997

CUBN 1.748 - - - 0.789 0.959 - Mlig455_009236 {REF} {Length: 3722} {Human: ENSG00000107611, CUBN, cubilin, [Score=60.1, Expect=9e-09]} {Mouse: ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=65.5, Expect=1e-10]} {Dmel: FBgn0261262, CG42613, [Score=145, Expect=2e-36]} {Celegans: WBGene00002977, lev-10, LEV-10B, [Score=120, Expect=2e-28]} {Smed: dd_Smed_v6_11447_0_1, dd_Smed_v6_11447_0_1, [Score=228, Expect=8e-65]} {RNA1509_40917} {RNA1310_5203.2, RNA1509_40917} {RNA1509_40917, RNA815_10358}
41. MligTC455_50294 12 0.26 Mlig455_056671

Neo: -

Age: -

PLEKHG7 1.746 - - 0.791 - 0.955 - Mlig455_056671 {REF} {Length: 2786} {Pfam: RhoGEF domain [PF00621.22, score=80.0]; Pleckstrin homology domain [PF16652.7, score=45.3]} {Human: ENSG00000187510, PLEKHG7, pleckstrin homology and RhoGEF domain containing G7, [Score=263, Expect=7e-77]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=122, Expect=4e-28]} {Dmel: FBgn0261556, CG42674, [Score=94.7, Expect=1e-19]} {Celegans: WBGene00022391, Y95B8A.12, [Score=295, Expect=4e-90]} {Smed: dd_Smed_v6_16856_0_1, dd_Smed_v6_16856_0_1, [Score=582, Expect=0.0]} {RNA1310_36890} {RNA815_64753}
42. MligTC455_44120 125 2.61 Mlig455_041513

Neo: -

Age: Up-Down-Down

Region-enriched R2: 7.169/0.00020

1.744 - - - 0.789 0.955 - Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344}
43. MligTC455_29262 96 2 Mlig455_038249

Neo: -

Age: Up-Down-Down, logFC(26M/2M)=0.738

1.735 - - - 0.778 0.957 - Mlig455_038249 {REF} {Length: 8932} {RNA1509_25125, RNA1509_25587, RNA1509_9188} {RNA1310_234.1, RNA1509_25125, RNA1509_25587} {RNA1509_25125, RNA1509_25587, RNA815_23.1}
44. MligTC455_10354 51 1.05 Mlig455_041267

Neo: -

Age: Up-Down-Down

STOM 1.732 - - 0.763 - 0.969 - Mlig455_041267 {REF} {Length: 3318} {Pfam: SPFH domain / Band 7 family [PF01145.27, score=115.0]; SPFH domain-Band 7 family [PF13421.8, score=21.0]} {Human: ENSG00000148175, STOM, stomatin, [RH, Score=355, Expect=5e-123]} {Mouse: ENSMUSG00000026880, Stom, stomatin, [Score=349, Expect=8e-121]} {Dmel: FBgn0260657, CG42540, [Score=362, Expect=1e-122]} {Celegans: WBGene00003166, mec-2, Mechanosensory protein 2, [RH, Score=382, Expect=3e-132]} {Smed: dd_Smed_v6_6396_0_1, dd_Smed_v6_6396_0_1, [RH, Score=428, Expect=2e-152]} {RNA1509_58645} {RNA1310_19440.1} {RNA815_9049.1}
45. MligTC455_15837 58 1.21 Mlig455_058574

Neo: -

Age: Up-Down-Up

PLEKHG5 1.727 - - - 0.746 0.981 - Mlig455_058574 {REF} {Length: 3473} {Pfam: RhoGEF domain [PF00621.22, score=89.0]; Pleckstrin homology domain [PF15405.8, score=20.1]} {Human: ENSG00000171680, PLEKHG5, pleckstrin homology and RhoGEF domain containing G5, [Score=191, Expect=1e-49]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=194, Expect=1e-50]} {Dmel: FBgn0261556, CG42674, [Score=147, Expect=1e-35]} {Celegans: WBGene00006476, rhgf-2, RHGF-2; RHo Guanine nucleotide exchange Factor, [RH, Score=142, Expect=3e-34]} {Smed: dd_Smed_v6_10072_0_1, dd_Smed_v6_10072_0_1, [Score=171, Expect=2e-44]} {RNA1310_47096} {RNA815_12538}
46. MligTC455_41106 42 0.88 Mlig455_010275

Neo: -

Age: -

Region-enriched R2: 5.386/0.03242

CALM1 1.722 - - - 0.761 0.961 - Mlig455_010275 {REF} {Length: 1557} {Pfam: EF hand [PF00036.34, score=32.5]; EF-hand domain pair [PF13499.8, score=30.4]; EF-hand domain [PF13405.8, score=29.3]} {Human: ENSG00000198668, CALM1, calmodulin 1, [Score=67.0, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=67.0, Expect=4e-14]; ENSG00000143933, CALM2, calmodulin 2, [Score=67.0, Expect=4e-14]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=67.0, Expect=3e-14]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=67.0, Expect=3e-14]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=3e-14]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.9, Expect=5e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=66.2, Expect=4e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=66.6, Expect=3e-14]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=66.6, Expect=2e-14]} {RNA1310_51265}
47. MligTC455_48320 81 1.69 Mlig455_008829

Neo: -

Age: Down-Down-Up

TOB1 1.72 - - - 0.763 0.957 - Mlig455_008829 {REF} {Length: 832} {Pfam: BTG family [PF07742.14, score=62.3]} {Human: ENSG00000141232, TOB1, transducer of ERBB2, 1, [Score=64.7, Expect=2e-12]} {Mouse: ENSMUSG00000037573, Tob1, transducer of ErbB-2.1, [Score=63.2, Expect=4e-12]} {Dmel: FBgn0028397, Tob, [Score=68.6, Expect=5e-14]} {Smed: dd_Smed_v6_7444_0_1, dd_Smed_v6_7444_0_1, [Score=75.1, Expect=5e-17]} {RNA1509_42403, RNA1509_59615} {RNA1310_49803, RNA1509_42403, RNA1509_59615}
48. MligTC455_46173 63 1.3 Mlig455_032091

Neo: Irradiation

Age: Up-Down-Up

SRR 1.719 - - - 0.747 0.972 - Mlig455_032091 {REF} {Length: 2590} {Pfam: Pyridoxal-phosphate dependent enzyme [PF00291.27, score=208.5]; ACT domain [PF01842.27, score=19.8]} {Human: ENSG00000167720, SRR, serine racemase, [Score=129, Expect=2e-32]} {Mouse: ENSMUSG00000001323, Srr, serine racemase, [Score=105, Expect=4e-24]} {Dmel: FBgn0037684, CG8129, [Score=373, Expect=5e-123]} {Celegans: WBGene00010456, K01C8.1, [Score=407, Expect=5e-136]} {Smed: dd_Smed_v6_6737_0_1, dd_Smed_v6_6737_0_1, [Score=474, Expect=7e-163]} {RNA1509_48789} {RNA1310_15074} {RNA815_9364}
49. MligTC455_35411 583 12.15 Mlig455_064235

Neo: -

Age: -

PPP3CA 1.717 - - - 0.757 0.960 - Mlig455_064235 {REF} {Length: 3595} {Human: ENSG00000138814, PPP3CA, protein phosphatase 3 catalytic subunit alpha, [Score=156, Expect=8e-46]; ENSG00000107758, PPP3CB, protein phosphatase 3 catalytic subunit beta, [Score=149, Expect=4e-43]} {Mouse: ENSMUSG00000028161, Ppp3ca, protein phosphatase 3, catalytic subunit, alpha isoform, [Score=158, Expect=1e-46]} {Dmel: FBgn0011826, Pp2B-14D, Protein phosphatase 2B at 14D, [Score=159, Expect=1e-46]} {Celegans: WBGene00006527, tax-6, Serine/threonine-protein phosphatase 2B catalytic subunit, [Score=115, Expect=1e-30]} {Smed: dd_Smed_v6_5669_1_2, dd_Smed_v6_5669_1_2, [Score=155, Expect=7e-49]} {RNA1509_42566} {RNA1310_30586} {RNA815_21103.2}
50. MligTC455_29201 1280 26.67 Mlig455_049817

Neo: -

Age: -

Regeneration-downregulated BL: -1.729

Regeneration-depleted BL: -1.729

OTOF 1.716 - - - 0.730 0.986 - Mlig455_049817 {REF} {Length: 7973} {Pfam: C2 domain [PF00168.32, score=225.3]; FerB (NUC096) domain [PF08150.14, score=99.1]; Ferlin C-terminus [PF16165.7, score=97.7]; FerI (NUC094) domain [PF08151.14, score=61.5]} {Human: ENSG00000115155, OTOF, otoferlin, [RH, Score=910, Expect=0.0]} {Mouse: ENSMUSG00000062372, Otof, otoferlin, [RH, Score=915, Expect=0.0]} {Dmel: FBgn0266757, mfr, misfire, [RH, Score=301, Expect=4e-84]} {Celegans: WBGene00001414, fer-1, Sperm vesicle fusion protein fer-1, [Score=150, Expect=9e-36]} {Smed: dd_Smed_v6_5915_0_1, dd_Smed_v6_5915_0_1, [Score=1476, Expect=0.0]} {RNA1509_5256} {RNA1310_1416.2} {RNA815_411.1}
51. MligTC455_36826 28 0.58 Mlig455_013198

Neo: -

Age: -

Region-enriched R2: 5.359/0.01396

HSPB6 1.713 - - 0.749 0.964 - - Mlig455_013198 {REF} {Length: 2372} {Pfam: Hsp20/alpha crystallin family [PF00011.23, score=56.3]} {Human: ENSG00000004776, HSPB6, heat shock protein family B (small) member 6, [RH, Score=55.5, Expect=8e-09]} {Mouse: ENSMUSG00000036854, Hspb6, heat shock protein, alpha-crystallin-related, B6, [RH, Score=58.5, Expect=7e-10]} {Dmel: FBgn0011296, l(2)efl, lethal (2) essential for life, [Score=57.8, Expect=1e-09]} {Smed: dd_Smed_v6_15128_0_1, dd_Smed_v6_15128_0_1, [RH, Score=81.3, Expect=3e-17]} {RNA1310_41920} {RNA815_42079}
52. MligTC455_44862 1318 27.47 Mlig455_028792

Neo: -

Age: -

Region-enriched R2: 3.389/0.00000

QPCT 1.712 - - - 0.756 0.956 - Mlig455_028792 {REF} {Length: 1901} {Pfam: Peptidase family M28 [PF04389.19, score=137.7]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [RH, Score=189, Expect=5e-57]; ENSG00000011478, QPCTL, glutaminyl-peptide cyclotransferase like, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [RH, Score=190, Expect=3e-57]; ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [RH, Score=189, Expect=5e-57]} {Dmel: FBgn0036999, isoQC, iso Glutaminyl cyclase, [RH, Score=210, Expect=2e-65]} {Celegans: WBGene00010418, H27A22.1, [Score=182, Expect=5e-55]} {Smed: dd_Smed_v6_4861_0_2, dd_Smed_v6_4861_0_2, [Score=166, Expect=1e-48]} {RNA1509_15042, RNA1509_18145} {RNA1310_21749, RNA1509_15042, RNA1509_18145} {RNA1509_15042, RNA1509_18145, RNA815_8635.1}
53. MligTC455_35802 114 2.38 Mlig455_051876, Mlig455_051902, Mlig455_053140

Neo: -

Age: -

CACNA2D1 1.709 - - - 0.756 0.953 -

Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380}

Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878}

Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878}
54. MligTC455_15996 396 8.26 Mlig455_064976, Mlig455_066809

Neo: -

Age: -

ARHGEF17 1.704 - - - 0.740 0.964 -

Mlig455_064976 {REF} {Length: 4968} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=136.4]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [Score=233, Expect=6e-61]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [Score=239, Expect=3e-63]} {Dmel: FBgn0262562, CG43102, [RH, Score=520, Expect=4e-156]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [RH, Score=240, Expect=2e-64]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=713, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_14497}

Mlig455_066809 {REF} {Length: 5061} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=125.9]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [RH, Score=266, Expect=2e-71]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [RH, Score=264, Expect=1e-70]} {Dmel: FBgn0262562, CG43102, [RH, Score=503, Expect=8e-150]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [Score=224, Expect=3e-59]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=691, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_23184}
55. MligTC455_35375 97 2.02 Mlig455_000108, Mlig455_056118, Mlig455_056902, Mlig455_061600, Mlig455_066534

Neo: -

Age: -

1.704 - - 0.953 - 0.751 -

Mlig455_000108 {REF} {Length: 627} {NoTransDecoderORF} {RNA1509_47429} {RNA1310_22662.1} {RNA815_42886}

Mlig455_056118 {REF} {Length: 627} {NoTransDecoderORF} {RNA1509_47429} {RNA1310_22662.1} {RNA815_42886}

Mlig455_056902 {REF} {Length: 628} {NoTransDecoderORF} {RNA1509_47429} {RNA1310_22662.1} {RNA815_42886}

Mlig455_061600 {REF} {Length: 823} {NoTransDecoderORF} {RNA1509_47429} {RNA1310_22662.1} {RNA815_42886}

Mlig455_066534 {REF} {Length: 672} {NoTransDecoderORF} {RNA1509_47429} {RNA1310_22662.1} {RNA815_42886}
56. MligTC455_39207 161 3.36 Mlig455_043588

Neo: -

Age: logFC(26M/2M)=-0.502

DCHS1 1.703 - - - 0.743 0.960 - Mlig455_043588 {REF} {Length: 8241} {Pfam: Cadherin domain [PF00028.19, score=487.6]; Cadherin-like [PF08266.14, score=41.6]; Cadherin-like [PF16184.7, score=29.4]; RET Cadherin like domain 1 [PF17756.3, score=27.8]} {Human: ENSG00000166341, DCHS1, dachsous cadherin-related 1, [Score=391, Expect=4e-110]; ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=375, Expect=5e-105]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=380, Expect=1e-106]; ENSMUSG00000036862, Dchs1, dachsous cadherin related 1, [Score=378, Expect=3e-106]} {Dmel: FBgn0284247, ds, dachsous, [Score=418, Expect=3e-119]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=201, Expect=1e-51]} {Smed: dd_Smed_v6_11744_0_1, dd_Smed_v6_11744_0_1, [Score=179, Expect=5e-45]} {RNA1509_5448} {RNA1310_281} {RNA815_2365}
57. MligTC455_52003 1043 21.73 Mlig455_050564, Mlig455_050571

Neo: -

Age: -

RGS4, RGS8 1.702 - - - 0.750 0.952 -

Mlig455_050564 {REF} {Length: 3240} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=116.7]} {Human: ENSG00000117152, RGS4, regulator of G protein signaling 4, [RH, Score=149, Expect=2e-42]} {Mouse: ENSMUSG00000038530, Rgs4, regulator of G-protein signaling 4, [RH, Score=153, Expect=4e-44]; ENSMUSG00000026678, Rgs5, regulator of G-protein signaling 5, [RH, Score=149, Expect=1e-42]; ENSMUSG00000042671, Rgs8, regulator of G-protein signaling 8, [RH, Score=149, Expect=1e-42]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=118, Expect=2e-30]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [Score=124, Expect=4e-33]} {Smed: dd_Smed_v6_8648_0_1, dd_Smed_v6_8648_0_1, [RH, Score=199, Expect=4e-58]} {RNA1509_11015, RNA1509_27306} {RNA1310_4876, RNA1509_11015, RNA1509_27306} {RNA1509_11015, RNA1509_27306, RNA815_6054}

Mlig455_050571 {REF} {Length: 2222} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=118.3]} {Human: ENSG00000135824, RGS8, regulator of G protein signaling 8, [RH, Score=149, Expect=9e-45]; ENSG00000117152, RGS4, regulator of G protein signaling 4, [RH, Score=149, Expect=2e-44]; ENSG00000150681, RGS18, regulator of G protein signaling 18, [RH, Score=146, Expect=5e-43]; ENSG00000143248, RGS5, regulator of G protein signaling 5, [RH, Score=144, Expect=7e-43]} {Mouse: ENSMUSG00000038530, Rgs4, regulator of G-protein signaling 4, [RH, Score=153, Expect=5e-46]; ENSMUSG00000042671, Rgs8, regulator of G-protein signaling 8, [RH, Score=151, Expect=1e-45]; ENSMUSG00000026678, Rgs5, regulator of G-protein signaling 5, [RH, Score=147, Expect=7e-44]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=117, Expect=1e-31]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [Score=124, Expect=7e-35]} {Smed: dd_Smed_v6_8648_0_1, dd_Smed_v6_8648_0_1, [RH, Score=192, Expect=1e-57]} {RNA1509_27306} {RNA1310_5436.1} {RNA815_6054}
58. MligTC455_19583 95 1.97 Mlig455_010583, Mlig455_010602

Neo: -

Age: -

Region-enriched R2: 6.442/0.00383

1.701 - - - 0.720 0.981 -

Mlig455_010583 {REF} {Length: 2325} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=173.5]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=320, Expect=4e-101]} {RNA1310_36131} {RNA815_32135}

Mlig455_010602 {REF} {Length: 2432} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=182.9]} {Smed: dd_Smed_v6_15099_0_1, dd_Smed_v6_15099_0_1, [RH, Score=346, Expect=2e-110]} {RNA1310_36131} {RNA815_32135}
59. MligTC455_41430 65 1.35 Mlig455_070915

Neo: -

Age: -

BHLHE22 1.701 - - - 0.726 0.975 - Mlig455_070915 {REF} {Length: 1052} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=58.4]} {Human: ENSG00000180828, BHLHE22, basic helix-loop-helix family member e22, [RH, Score=135, Expect=4e-37]} {Mouse: ENSMUSG00000025128, Bhlhe22, basic helix-loop-helix family, member e22, [RH, Score=133, Expect=8e-37]; ENSMUSG00000045493, Bhlhe23, basic helix-loop-helix family, member e23, [RH, Score=129, Expect=1e-36]} {Dmel: FBgn0032651, Oli, Olig family, [RH, Score=135, Expect=4e-39]} {Celegans: WBGene00001961, hlh-17, Helix Loop Helix, [RH, Score=103, Expect=2e-28]} {Smed: dd_Smed_v6_12722_0_1, dd_Smed_v6_12722_0_1, [RH, Score=129, Expect=2e-37]} {RNA1310_107478}
60. MligTC455_12992 102 2.12 Mlig455_034920

Neo: -

Age: -

Region-enriched R2: 3.155/0.02568

RAC2 1.7 - - - 0.736 0.964 - Mlig455_034920 {REF} {Length: 3245} {Pfam: Ras family [PF00071.24, score=175.5]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=80.0]; ADP-ribosylation factor family [PF00025.23, score=32.7]} {Human: ENSG00000128340, RAC2, Rac family small GTPase 2, [Score=277, Expect=1e-95]; ENSG00000136238, RAC1, Rac family small GTPase 1, [Score=273, Expect=6e-94]} {Mouse: ENSMUSG00000033220, Rac2, Rac family small GTPase 2, [Score=275, Expect=3e-95]; ENSMUSG00000001847, Rac1, Rac family small GTPase 1, [Score=273, Expect=4e-94]; ENSMUSG00000018012, Rac3, Rac family small GTPase 3, [Score=263, Expect=3e-90]} {Dmel: FBgn0010333, Rac1, [Score=270, Expect=2e-93]} {Celegans: WBGene00000424, ced-10, Ras-related protein ced-10, [Score=268, Expect=2e-92]} {Smed: dd_Smed_v6_610_0_1, dd_Smed_v6_610_0_1, [Score=251, Expect=4e-86]} {RNA1509_26483} {RNA1310_31644} {RNA815_16762}
61. MligTC455_29202 397 8.26 Mlig455_016520

Neo: -

Age: Up-Down-Up

OTOF 1.698 - - - 0.725 0.973 - Mlig455_016520 {REF} {Length: 3035} {Pfam: C2 domain [PF00168.32, score=46.4]} {Human: ENSG00000115155, OTOF, otoferlin, [Score=310, Expect=3e-90]} {Mouse: ENSMUSG00000062372, Otof, otoferlin, [Score=302, Expect=6e-88]} {Dmel: FBgn0266757, mfr, misfire, [Score=131, Expect=1e-31]} {Celegans: WBGene00001414, fer-1, Sperm vesicle fusion protein fer-1, [Score=73.6, Expect=4e-13]} {Smed: dd_Smed_v6_5915_0_1, dd_Smed_v6_5915_0_1, [Score=452, Expect=6e-140]} {RNA1509_5256} {RNA1310_1035} {RNA815_411.1}
62. MligTC455_47393 241 5.03 Mlig455_008718, Mlig455_063579

Neo: -

Age: Down-Up-Down

Region-enriched R2: 3.683/0.00849

CALM2 1.696 - - - 0.729 0.967 -

Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211}

Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211}
63. MligTC455_40756 35 0.73 Mlig455_050356, Mlig455_065112

Neo: -

Age: -

1.695 - - - 0.974 0.721 -

Mlig455_050356 {REF} {Length: 740} {NoTransDecoderORF} {RNA1509_38191} {RNA1310_5321.1} {RNA815_14836}

Mlig455_065112 {REF} {Length: 277} {NoTransDecoderORF} {RNA1509_38191} {RNA1310_5321.1} {RNA815_14836}
64. MligTC455_05879 15 0.32 Mlig455_063605

Neo: -

Age: -

1.693 - - - 0.738 0.955 - Mlig455_063605 {REF} {Length: 563} {NoTransDecoderORF} {RNA1509_52081} {RNA1310_66924} {RNA815_45160}
65. MligTC455_50172 243 5.05 Mlig455_067182

Neo: -

Age: Down-Up-Up

Region-specific R2: 6.036

Region-enriched R2: 6.524/0.00000

1.69 - - - 0.730 0.960 - Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1}
66. MligTC455_53414 331 6.9 Mlig455_053442

Neo: -

Age: -

Region-specific R2: 4.308

Region-enriched R2: 3.374/0.00040

RP1 1.687 - - - 0.726 0.961 - Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1}
67. MligTC455_24953 749 15.61 Mlig455_060716

Neo: -

Age: -

Region-specific R2: 5.313

Region-enriched R2: 5.509/0.00000

CCDC169 1.686 - - 0.729 - 0.957 - Mlig455_060716 {REF} {Length: 1302} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545}
68. MligTC455_49843 70 1.46 Mlig455_058264, Mlig455_058281, Mlig455_070786

Neo: -

Age: -

CHRNA3, CHRNA7 1.686 - - 0.950 - 0.736 -

Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862}

Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862}

Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410}
69. MligTC455_25928 181 3.78 Mlig455_006534, Mlig455_006538, Mlig455_006649, Mlig455_006700

Neo: -

Age: logFC(26M/2M)=-0.528

Region-specific R2: 7.256

Region-enriched R2: 5.788/0.02697

1.685 - - - 0.719 0.966 -

Mlig455_006534 {REF} {Length: 689} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2}

Mlig455_006538 {REF} {Length: 1691} {RNA1509_12380} {RNA1310_164.2} {RNA815_19957}

Mlig455_006649 {REF} {Length: 829} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2}

Mlig455_006700 {REF} {Length: 750} {RNA1509_22927} {RNA1310_81957.2} {RNA815_41771.2}
70. MligTC455_53415 319 6.64 Mlig455_053444

Neo: -

Age: Up-Down-Down

Region-specific R2: 4.862

Region-enriched R2: 4.179/0.00011

RP1 1.683 - - - 0.722 0.961 - Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469}
71. MligTC455_09313 673 14.01 Mlig455_021865, Mlig455_021943

Neo: -

Age: Up-Down-Down

Region-enriched R2: 2.967/0.00176

1.681 - - - 0.705 0.976 -

Mlig455_021865 {REF} {Length: 5096} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [Score=79.3, Expect=1e-14]} {RNA1509_22941} {RNA1310_4839.1} {RNA815_8984}

Mlig455_021943 {REF} {Length: 5863} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [RH, Score=83.6, Expect=7e-16]} {RNA1509_22941} {RNA1310_4839.1, RNA1509_22941} {RNA1509_22941, RNA815_15728}
72. MligTC455_24985 43 0.89 Mlig455_005348, Mlig455_005464

Neo: -

Age: -

ADRA1A, HTR1A 1.681 - - - 0.724 0.957 -

Mlig455_005348 {REF} {Length: 1845} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=222.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=41.4]} {Human: ENSG00000120907, ADRA1A, adrenoceptor alpha 1A, [Score=186, Expect=3e-54]; ENSG00000178394, HTR1A, 5-hydroxytryptamine receptor 1A, [Score=184, Expect=1e-53]; ENSG00000170214, ADRA1B, adrenoceptor alpha 1B, [Score=179, Expect=1e-50]} {Mouse: ENSMUSG00000045875, Adra1a, adrenergic receptor, alpha 1a, [Score=181, Expect=1e-52]; ENSMUSG00000021721, Htr1a, 5-hydroxytryptamine (serotonin) receptor 1A, [Score=179, Expect=5e-52]; ENSMUSG00000050541, Adra1b, adrenergic receptor, alpha 1b, [Score=179, Expect=7e-51]} {Dmel: FBgn0011582, Dop1R1, Dopamine 1-like receptor 1, [Score=162, Expect=3e-45]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=181, Expect=7e-53]} {Smed: dd_Smed_v6_33950_0_1, dd_Smed_v6_33950_0_1, [Score=254, Expect=1e-80]} {RNA1310_56787}

Mlig455_005464 {REF} {Length: 1742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=223.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.7]; Presenilin [PF01080.19, score=17.5]} {Human: ENSG00000178394, HTR1A, 5-hydroxytryptamine receptor 1A, [Score=194, Expect=7e-57]; ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=191, Expect=4e-55]} {Mouse: ENSMUSG00000058620, Adra2b, adrenergic receptor, alpha 2b, [RH, Score=184, Expect=5e-53]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=172, Expect=1e-46]} {Celegans: WBGene00017157, tyra-2, Tyramine receptor tyra-2, [RH, Score=216, Expect=3e-65]} {Smed: dd_Smed_v6_33950_0_1, dd_Smed_v6_33950_0_1, [RH, Score=329, Expect=1e-108]} {RNA1310_56787}
73. MligTC455_16907 87 1.82 Mlig455_008705

Neo: -

Age: Down-Up-Down

SLC17A8 1.677 - - - 0.719 0.958 - Mlig455_008705 {REF} {Length: 1949} {Pfam: Major Facilitator Superfamily [PF07690.18, score=37.9]; SOCE-associated regulatory factor of calcium homoeostasis [PF06682.14, score=19.6]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [Score=213, Expect=1e-65]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=212, Expect=1e-64]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=208, Expect=6e-64]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=215, Expect=1e-67]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=211, Expect=1e-64]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=207, Expect=4e-63]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=196, Expect=1e-58]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=189, Expect=1e-56]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=234, Expect=3e-73]} {RNA1509_38152} {RNA1310_19607.1} {RNA815_14894}
74. MligTC455_45912 1103 22.98 Mlig455_006912

Neo: -

Age: -

Region-specific R2: 3.366

Region-enriched R2: 1.790/0.00307

1.673 - - - 0.720 0.953 - Mlig455_006912 {REF} {Length: 1066} {RNA1509_32903, RNA1509_42927} {RNA1310_38334, RNA1509_42927} {RNA1509_42927, RNA815_18393}
75. MligTC455_42484 246 5.12 Mlig455_046416

Neo: -

Age: Down-Up-Down

Region-specific R2: 4.313

Region-enriched R2: 2.983/0.00930

1.672 - - - 0.720 0.952 - Mlig455_046416 {REF} {Length: 1006} {RNA1310_40237.1} {RNA815_18246}
76. MligTC455_07030 347 7.23 Mlig455_026901, Mlig455_030792, Mlig455_048033

Neo: -

Age: Up-Down-Down

Region-enriched R8: 3.182/0.03347
Region-enriched R2: 3.034/0.01060

KIF1A 1.664 - - - 0.702 0.962 -

Mlig455_026901 {REF} {Length: 5213} {Pfam: Kinesin-associated [PF16183.7, score=194.5]; Kinesin protein [PF12473.10, score=106.0]; PH domain [PF00169.31, score=42.3]; Kinesin protein 1B [PF12423.10, score=37.6]; FHA domain [PF00498.28, score=32.9]; Kinesin motor domain [PF00225.25, score=25.4]; Inner membrane component of T3SS, cytoplasmic domain [PF16697.7, score=25.3]} {Human: ENSG00000130294, KIF1A, kinesin family member 1A, [Score=966, Expect=0.0]} {Mouse: ENSMUSG00000014602, Kif1a, kinesin family member 1A, [Score=962, Expect=0.0]} {Dmel: FBgn0267002, unc-104, uncoordinated-104, [Score=967, Expect=0.0]} {Celegans: WBGene00006831, unc-104, Kinesin-like protein unc-104, [Score=865, Expect=0.0]} {Smed: dd_Smed_v6_7108_0_1, dd_Smed_v6_7108_0_1, [Score=1137, Expect=0.0]} {RNA1509_24107} {RNA1310_2812.1} {RNA815_13100}

Mlig455_030792 {REF} {Length: 6718} {Pfam: Kinesin motor domain [PF00225.25, score=369.4]; Kinesin-associated [PF16183.7, score=194.3]; Kinesin protein [PF12473.10, score=105.2]; Microtubule binding [PF16796.7, score=64.0]; PH domain [PF00169.31, score=42.1]; Kinesin protein 1B [PF12423.10, score=37.6]; FHA domain [PF00498.28, score=33.7]; Inner membrane component of T3SS, cytoplasmic domain [PF16697.7, score=25.0]} {Human: ENSG00000130294, KIF1A, kinesin family member 1A, [Score=1434, Expect=0.0]} {Mouse: ENSMUSG00000014602, Kif1a, kinesin family member 1A, [Score=1431, Expect=0.0]} {Dmel: FBgn0267002, unc-104, uncoordinated-104, [Score=1431, Expect=0.0]} {Celegans: WBGene00006831, unc-104, Kinesin-like protein unc-104, [RH, Score=1296, Expect=0.0]} {Smed: dd_Smed_v6_7108_0_2, dd_Smed_v6_7108_0_2, [Score=1566, Expect=0.0]} {RNA1509_24107} {RNA1310_2896} {RNA815_13100}

Mlig455_048033 {REF} {Length: 116} {NoTransDecoderORF} {RNA1310_101965} {RNA815_46048}
77. MligTC455_17286 18 0.37 Mlig455_062850, Mlig455_062932

Neo: -

Age: -

NPFFR2, QRFPR 1.655 - - 0.701 - 0.954 -

Mlig455_062850 {REF} {Length: 2774} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=136.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=29.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=17.9]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=132, Expect=1e-33]; ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=130, Expect=4e-33]} {Mouse: ENSMUSG00000031212, Pgr15l, G protein-coupled receptor 15-like, [Score=137, Expect=9e-36]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=138, Expect=9e-36]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=95.1, Expect=4e-21]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=105, Expect=1e-24]} {RNA1310_125205}

Mlig455_062932 {REF} {Length: 1463} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=135.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=29.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=19.2]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=129, Expect=7e-33]; ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=128, Expect=2e-32]} {Mouse: ENSMUSG00000031212, Pgr15l, G protein-coupled receptor 15-like, [Score=138, Expect=8e-36]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=136, Expect=4e-35]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=95.1, Expect=4e-21]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=105, Expect=1e-24]} {RNA1310_125205}
78. MligTC455_24064 359 7.48 Mlig455_048183

Neo: -

Age: -

SNAP25 0.993 - - - - 0.993 - Mlig455_048183 {REF} {Length: 1315} {Pfam: SNAP-25 family [PF00835.21, score=41.5]} {Human: ENSG00000132639, SNAP25, synaptosome associated protein 25, [Score=219, Expect=7e-72]} {Mouse: ENSMUSG00000027273, Snap25, synaptosomal-associated protein 25, [Score=219, Expect=5e-72]} {Dmel: FBgn0266720, Snap24, Synaptosomal-associated protein 24kDa, [RH, Score=228, Expect=1e-75]} {Celegans: WBGene00004364, ric-4, Synaptosomal-associated protein, [RH, Score=257, Expect=2e-87]} {Smed: dd_Smed_v6_3977_0_1, dd_Smed_v6_3977_0_1, [RH, Score=282, Expect=2e-97]} {RNA1509_8624} {RNA1310_24253} {RNA815_10439}
79. MligTC455_35505 126 2.62 Mlig455_018997, Mlig455_022533, Mlig455_055707

Neo: -

Age: -

HRH2, SYT7 0.99 - - - - 0.990 -

Mlig455_018997 {REF} {Length: 4854} {Pfam: C2 domain [PF00168.32, score=156.5]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=271, Expect=9e-84]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=261, Expect=3e-81]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [RH, Score=243, Expect=4e-76]} {Celegans: WBGene00004926, snt-6, SyNapTotagmin, [RH, Score=182, Expect=1e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=199, Expect=6e-60]} {RNA1310_29722} {RNA815_16467}

Mlig455_022533 {REF} {Length: 1223} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=80.1]} {Human: ENSG00000113749, HRH2, histamine receptor H2, [Score=68.6, Expect=4e-12]} {Mouse: ENSMUSG00000044338, Aplnr, apelin receptor, [Score=64.3, Expect=7e-11]; ENSMUSG00000037424, Taar9, trace amine-associated receptor 9, [Score=63.9, Expect=9e-11]; ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=63.2, Expect=2e-10]} {Dmel: FBgn0039595, AstA-R2, Allatostatin A receptor 2, [Score=53.1, Expect=2e-07]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [Score=63.2, Expect=9e-11]}

Mlig455_055707 {REF} {Length: 2803} {Pfam: C2 domain [PF00168.32, score=156.6]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=270, Expect=2e-83]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=259, Expect=4e-81]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [RH, Score=243, Expect=2e-76]} {Celegans: WBGene00004926, snt-6, SyNapTotagmin, [RH, Score=182, Expect=1e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=199, Expect=4e-60]} {RNA1310_29722} {RNA815_16467}
80. MligTC455_41226 44 0.92 Mlig455_019357, Mlig455_059122

Neo: -

Age: -

GALNT1 0.99 - - - - 0.990 -

Mlig455_019357 {REF} {Length: 1606} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=97.5]; Glycosyltransferase like family 2 [PF13641.8, score=38.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.1]; Glycosyltransferase like family 2 [PF10111.11, score=18.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=318, Expect=2e-103]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=311, Expect=4e-100]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=305, Expect=3e-98]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=305, Expect=3e-98]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=316, Expect=1e-102]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=308, Expect=9e-99]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=302, Expect=3e-97]} {Dmel: FBgn0050463, CG30463, [Score=345, Expect=5e-113]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=350, Expect=3e-115]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=353, Expect=1e-117]} {RNA1310_25598} {RNA815_36943}

Mlig455_059122 {REF} {Length: 2150} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=96.4]; Glycosyltransferase like family 2 [PF13641.8, score=35.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=313, Expect=2e-101]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=307, Expect=2e-98]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=300, Expect=6e-96]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=299, Expect=7e-96]; ENSG00000144278, GALNT13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=1e-95]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=311, Expect=1e-100]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=305, Expect=1e-97]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=8e-96]; ENSMUSG00000026994, Galnt3, polypeptide N-acetylgalactosaminyltransferase 3, [Score=296, Expect=5e-94]; ENSMUSG00000026828, Galnt5, polypeptide N-acetylgalactosaminyltransferase 5, [Score=296, Expect=2e-91]} {Dmel: FBgn0050463, CG30463, [Score=340, Expect=3e-111]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=344, Expect=3e-113]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=350, Expect=3e-116]} {RNA1310_25598} {RNA815_36943}
81. MligTC455_19079 218 4.54 Mlig455_008746, Mlig455_008760

Neo: -

Age: Down-Up-Up

Region-specific R2: 6.705

Region-enriched R2: 6.864/0.00152

0.989 - - - - 0.989 -

Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524}

Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524}
82. MligTC455_53381 34 0.7 Mlig455_032765

Neo: -

Age: -

0.988 - - - - 0.988 - Mlig455_032765 {REF} {Length: 552} {NoTransDecoderORF}
83. MligTC455_05124 30 0.63 Mlig455_013049

Neo: -

Age: -

0.986 - - - - 0.986 - Mlig455_013049 {REF} {Length: 875} {Pfam: Lectin C-type domain [PF00059.23, score=28.5]} {RNA1509_20946} {RNA1310_85223} {RNA815_4785.4}
84. MligTC455_15836 36 0.74 Mlig455_000292

Neo: -

Age: Up-Down-Down

PLEKHG5 0.986 - - - - 0.986 - Mlig455_000292 {REF} {Length: 4512} {Pfam: RhoGEF domain [PF00621.22, score=89.5]; PH domain [PF17838.3, score=20.5]; Pleckstrin homology domain [PF15405.8, score=19.2]} {Human: ENSG00000171680, PLEKHG5, pleckstrin homology and RhoGEF domain containing G5, [Score=197, Expect=6e-52]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=199, Expect=5e-53]} {Dmel: FBgn0261556, CG42674, [Score=147, Expect=6e-36]} {Celegans: WBGene00006476, rhgf-2, RHGF-2; RHo Guanine nucleotide exchange Factor, [RH, Score=147, Expect=3e-36]} {Smed: dd_Smed_v6_10072_0_1, dd_Smed_v6_10072_0_1, [RH, Score=179, Expect=8e-48]} {RNA1310_47096} {RNA815_53026}
85. MligTC455_16868 51 1.06 Mlig455_031982

Neo: -

Age: -

0.983 - - - - 0.983 - Mlig455_031982 {REF} {Length: 20475} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.5]} {RNA1509_48742} {RNA1310_30310.1} {RNA815_48195}
86. MligTC455_04162 131 2.73 Mlig455_028924

Neo: -

Age: Up-Down-Down, logFC(26M/2M)=-0.575

HMCN1 0.982 - - - - 0.982 - Mlig455_028924 {REF} {Length: 3929} {Pfam: Immunoglobulin domain [PF13927.8, score=144.9]; Immunoglobulin I-set domain [PF07679.18, score=119.8]; Immunoglobulin domain [PF13895.8, score=113.4]; Immunoglobulin domain [PF00047.27, score=102.3]; Immunoglobulin V-set domain [PF07686.19, score=36.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=35.3]; Immunoglobulin C1-set domain [PF07654.17, score=23.3]; C17orf99 Ig domain [PF17736.3, score=20.9]; Immunoglobulin domain [PF18452.3, score=19.8]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=103, Expect=2e-21]; ENSG00000148357, HMCN2, hemicentin 2, [Score=100, Expect=8e-21]} {Mouse: ENSMUSG00000051747, Ttn, titin, [Score=107, Expect=5e-23]; ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=103, Expect=7e-22]} {Dmel: FBgn0000547, ed, echinoid, [Score=147, Expect=2e-35]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=100, Expect=3e-21]} {Smed: dd_Smed_v6_13903_0_1, dd_Smed_v6_13903_0_1, [Score=162, Expect=2e-40]} {RNA1310_26618} {RNA815_41641}
87. MligTC455_17197 170 3.54 Mlig455_053652

Neo: -

Age: -

0.982 - - - - 0.982 - Mlig455_053652 {REF} {Length: 2429} {TRANSSPLICED} {RNA1509_44480} {RNA1310_34935, RNA1509_44480} {RNA1509_44480, RNA815_20343}
88. MligTC455_11473 248 5.17 Mlig455_009711, Mlig455_071036

Neo: -

Age: Down-Up-Down

CHRNA3 0.98 - - - - 0.980 -

Mlig455_009711 {REF} {Length: 2402} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=241.4]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=391, Expect=2e-130]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=379, Expect=6e-126]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=375, Expect=2e-124]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=390, Expect=2e-130]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=375, Expect=2e-124]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [RH, Score=499, Expect=9e-173]} {Celegans: WBGene00000043, acr-3, Acetylcholine receptor subunit beta-type acr-3, [RH, Score=426, Expect=6e-145]} {Smed: dd_Smed_v6_12146_0_1, dd_Smed_v6_12146_0_1, [Score=510, Expect=1e-176]} {RNA1509_48201} {RNA1310_10118} {RNA815_29940}

Mlig455_071036 {REF} {Length: 746} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.1]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [Score=63.5, Expect=2e-13]} {Celegans: WBGene00000042, acr-2, Acetylcholine receptor subunit beta-type acr-2, [Score=63.9, Expect=9e-14]} {Smed: dd_Smed_v6_12535_0_1, dd_Smed_v6_12535_0_1, [Score=64.3, Expect=6e-14]} {RNA1310_21182} {RNA815_29940}
89. MligTC455_08913 11 0.23 Mlig455_010158, Mlig455_010225

Neo: -

Age: -

KCNN1 0.979 - - - 0.979 - -

Mlig455_010158 {REF} {Length: 2236} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=124.1]; Calmodulin binding domain [PF02888.18, score=76.7]; Ion channel [PF07885.18, score=53.1]} {Human: ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=384, Expect=2e-128]; ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=378, Expect=1e-125]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=374, Expect=3e-122]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=378, Expect=8e-126]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=372, Expect=1e-121]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=369, Expect=1e-122]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=369, Expect=1e-122]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=390, Expect=3e-131]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=318, Expect=3e-102]} {Smed: dd_Smed_v6_13309_0_1, dd_Smed_v6_13309_0_1, [Score=451, Expect=4e-156]} {RNA1310_35938} {RNA815_50883}

Mlig455_010225 {REF} {Length: 2486} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=124.1]; Calmodulin binding domain [PF02888.18, score=76.7]; Ion channel [PF07885.18, score=53.1]} {Human: ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=384, Expect=2e-128]; ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=378, Expect=1e-125]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=374, Expect=3e-122]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=378, Expect=8e-126]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=372, Expect=1e-121]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=369, Expect=1e-122]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=369, Expect=1e-122]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=390, Expect=3e-131]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=318, Expect=3e-102]} {Smed: dd_Smed_v6_13309_0_1, dd_Smed_v6_13309_0_1, [Score=451, Expect=4e-156]} {RNA1310_35938} {RNA815_50883}
90. MligTC455_17089 173 3.6 Mlig455_022974

Neo: -

Age: -

Region-enriched R4: 2.568/0.01700

0.977 - - - - 0.977 - Mlig455_022974 {REF} {Length: 1697} {RNA1509_56619} {RNA1310_21133.1} {RNA815_8631.1}
91. MligTC455_35739 91 1.9 Mlig455_050779

Neo: -

Age: Up-Down-Down

ADGRL2 0.977 - - - - 0.977 - Mlig455_050779 {REF} {Length: 4277} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=110.1]; Pentaxin family [PF00354.19, score=43.4]; Hormone receptor domain [PF02793.24, score=35.9]; Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=33.0]; GPCR-Autoproteolysis INducing (GAIN) domain [PF16489.7, score=20.5]; Myc amino-terminal region [PF01056.20, score=18.8]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=140, Expect=5e-33]; ENSG00000072071, ADGRL1, adhesion G protein-coupled receptor L1, [RH, Score=139, Expect=2e-32]; ENSG00000150471, ADGRL3, adhesion G protein-coupled receptor L3, [RH, Score=133, Expect=9e-31]} {Mouse: ENSMUSG00000028184, Adgrl2, adhesion G protein-coupled receptor L2, [RH, Score=142, Expect=1e-33]; ENSMUSG00000013033, Adgrl1, adhesion G protein-coupled receptor L1, [RH, Score=140, Expect=6e-33]} {Celegans: WBGene00002252, lat-2, Latrophilin-like protein LAT-2, [RH, Score=124, Expect=2e-28]} {Smed: dd_Smed_v6_16446_0_2, dd_Smed_v6_16446_0_2, [RH, Score=444, Expect=1e-139]} {RNA1509_25495} {RNA1310_3070} {RNA815_2153}
92. MligTC455_37315 84 1.76 Mlig455_048842

Neo: -

Age: -

CALM2 0.977 - - - - 0.977 - Mlig455_048842 {REF} {Length: 1287} {Pfam: EF-hand domain pair [PF13499.8, score=22.7]; EF-hand domain [PF14658.8, score=19.6]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=68.9, Expect=6e-14]; ENSG00000198668, CALM1, calmodulin 1, [Score=68.2, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=66.6, Expect=2e-13]; ENSG00000178363, CALML3, calmodulin like 3, [Score=65.5, Expect=4e-13]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=2e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=66.6, Expect=1e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=66.6, Expect=1e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=68.6, Expect=1e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=68.6, Expect=1e-14]} {Smed: dd_Smed_v6_5491_0_1, dd_Smed_v6_5491_0_1, [Score=110, Expect=3e-30]} {RNA1310_33365} {RNA815_27013}
93. MligTC455_44094 90 1.88 Mlig455_018759

Neo: -

Age: -

PCDH17 0.977 - - - - 0.977 - Mlig455_018759 {REF} {Length: 3612} {Pfam: Cadherin domain [PF00028.19, score=240.7]; Cadherin-like [PF16184.7, score=28.6]; Cadherin-like [PF08266.14, score=27.8]} {Human: ENSG00000118946, PCDH17, protocadherin 17, [RH, Score=263, Expect=1e-73]} {Mouse: ENSMUSG00000035566, Pcdh17, protocadherin 17, [RH, Score=264, Expect=7e-73]; ENSMUSG00000051323, Pcdh19, protocadherin 19, [RH, Score=261, Expect=6e-72]; ENSMUSG00000104063, Pcdhgb7, protocadherin gamma subfamily B, 7, [RH, Score=260, Expect=2e-72]} {Dmel: FBgn0024836, stan, starry night, [Score=215, Expect=1e-56]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=176, Expect=2e-44]} {Smed: dd_Smed_v6_21489_0_1, dd_Smed_v6_21489_0_1, [Score=283, Expect=5e-81]} {RNA1509_38737} {RNA1310_26793, RNA1509_38737} {RNA1509_38737, RNA815_46826}
94. MligTC455_23977 63 1.31 Mlig455_012689

Neo: -

Age: -

Regeneration-downregulated R5: -6.245

Regeneration-depleted R5: -6.245

DRD2 0.976 - - - - 0.976 - Mlig455_012689 {REF} {Length: 2124} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=191.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=32.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.4]} {Human: ENSG00000149295, DRD2, dopamine receptor D2, [Score=170, Expect=1e-46]} {Mouse: ENSMUSG00000032259, Drd2, dopamine receptor D2, [Score=168, Expect=4e-46]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [RH, Score=160, Expect=4e-43]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=159, Expect=2e-42]} {Smed: dd_Smed_v6_27884_0_1, dd_Smed_v6_27884_0_1, [Score=198, Expect=7e-57]} {RNA1310_28840} {RNA815_30584}
95. MligTC455_49296 69 1.44 Mlig455_034352, Mlig455_034414

Neo: -

Age: -

0.975 - - - - 0.975 -

Mlig455_034352 {REF} {Length: 912} {TRANSSPLICED}

Mlig455_034414 {REF} {Length: 919} {TRANSSPLICED}
96. MligTC455_12776 17 0.36 Mlig455_064082

Neo: -

Age: -

0.974 - - - - 0.974 - Mlig455_064082 {REF} {Length: 2904} {RNA1310_64520} {RNA815_36721}
97. MligTC455_28786 36 0.76 Mlig455_060723

Neo: -

Age: -

ANKRD17 0.973 - - - - 0.973 - Mlig455_060723 {REF} {Length: 6125} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=81.7]; Ankyrin repeats (many copies) [PF13857.8, score=61.4]; Ankyrin repeats (many copies) [PF13637.8, score=57.1]; Ankyrin repeat [PF13606.8, score=49.1]; Ankyrin repeat [PF00023.32, score=45.2]; Mab-21 protein [PF03281.16, score=26.5]} {Human: ENSG00000132466, ANKRD17, ankyrin repeat domain 17, [Score=80.9, Expect=1e-14]; ENSG00000131503, ANKHD1, ankyrin repeat and KH domain containing 1, [Score=80.9, Expect=1e-14]; ENSG00000254996, ANKHD1-EIF4EBP3, ANKHD1-EIF4EBP3 readthrough, [Score=80.1, Expect=2e-14]; ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=80.1, Expect=2e-14]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=81.3, Expect=5e-15]; ENSMUSG00000055204, Ankrd17, ankyrin repeat domain 17, [Score=80.5, Expect=1e-14]; ENSMUSG00000024483, Ankhd1, ankyrin repeat and KH domain containing 1, [Score=77.8, Expect=9e-14]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=74.7, Expect=5e-13]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=66.6, Expect=1e-10]} {Smed: dd_Smed_v6_6779_0_1, dd_Smed_v6_6779_0_1, [Score=87.0, Expect=5e-17]} {RNA1509_26281} {RNA1310_4721} {RNA815_5358.1}
98. MligTC455_38158 2649 55.19 Mlig455_017146, Mlig455_019684

Neo: -

Age: -

ABCA1 0.973 - - - - 0.973 -

Mlig455_017146 {REF} {Length: 8261} {TRANSSPLICED} {Pfam: ABC transporter [PF00005.29, score=164.2]; ABC-2 family transporter protein [PF12698.9, score=163.8]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=67.7]} {Human: ENSG00000165029, ABCA1, ATP binding cassette subfamily A member 1, [Score=1144, Expect=0.0]} {Mouse: ENSMUSG00000015243, Abca1, ATP-binding cassette, sub-family A (ABC1), member 1, [Score=1146, Expect=0.0]} {Dmel: FBgn0031170, CG1718, [Score=440, Expect=5e-126]} {Celegans: WBGene00000022, abt-4, ABC Transporter family, [Score=367, Expect=2e-102]} {Smed: dd_Smed_v6_2300_0_3, dd_Smed_v6_2300_0_3, [Score=1041, Expect=0.0]} {RNA1509_5078} {RNA1310_229.1, RNA1509_5078} {RNA1509_5078, RNA815_12546}

Mlig455_019684 {REF} {Length: 8212} {Pfam: ABC-2 family transporter protein [PF12698.9, score=166.6]; ABC transporter [PF00005.29, score=164.4]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=64.8]; AAA domain [PF13476.8, score=20.2]} {Human: ENSG00000165029, ABCA1, ATP binding cassette subfamily A member 1, [Score=1155, Expect=0.0]} {Mouse: ENSMUSG00000015243, Abca1, ATP-binding cassette, sub-family A (ABC1), member 1, [Score=1156, Expect=0.0]} {Dmel: FBgn0031170, CG1718, [Score=436, Expect=1e-124]} {Celegans: WBGene00000022, abt-4, ABC Transporter family, [Score=367, Expect=2e-102]} {Smed: dd_Smed_v6_2300_0_4, dd_Smed_v6_2300_0_4, [Score=1075, Expect=0.0]} {RNA1509_5078} {RNA1310_229.1} {RNA815_12546}
99. MligTC455_47601 126 2.62 Mlig455_056477

Neo: -

Age: Up-Down-Up

NRXN1 0.973 - - - - 0.973 - Mlig455_056477 {REF} {Length: 3481} {Pfam: Laminin G domain [PF02210.26, score=58.3]; Laminin G domain [PF00054.25, score=43.2]; Syndecan domain [PF01034.22, score=27.4]} {Human: ENSG00000179915, NRXN1, neurexin 1, [Score=142, Expect=4e-35]} {Mouse: ENSMUSG00000024109, Nrxn1, neurexin I, [Score=142, Expect=1e-35]} {Dmel: FBgn0038975, Nrx-1, Neurexin 1, [Score=102, Expect=2e-22]} {Smed: dd_Smed_v6_13697_0_1, dd_Smed_v6_13697_0_1, [Score=142, Expect=8e-36]} {RNA1509_55888} {RNA1310_37025, RNA1509_55888} {RNA1509_55888, RNA815_22404}
100. MligTC455_19040 49 1.03 Mlig455_003437

Neo: -

Age: -

Region-enriched R2: 6.133/0.00615
Region-enriched R3: 4.021/0.03085

CAV1 0.972 - - - - 0.972 - Mlig455_003437 {REF} {Length: 808} {Pfam: Caveolin [PF01146.19, score=118.3]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=101, Expect=7e-28]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=102, Expect=2e-28]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=73.6, Expect=9e-17]} {Smed: dd_Smed_v6_13481_0_1, dd_Smed_v6_13481_0_1, [RH, Score=142, Expect=8e-45]} {RNA1509_53381} {RNA1310_97043} {RNA815_32565}

There are 105 more genes with r >= 0.95  Show all


Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA